Mediclinic Intnl plc - Director/PDMR Shareholding

05/08/2022

PDF Version
RNS Number : 1314V
Mediclinic International plc
05 August 2022
 

Mediclinic International plc

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

South African income tax number: 9432434182

('Mediclinic', the 'Company', or the 'Group')

 

 

5 August 2022

 

NOTIFICATION: TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES & PERSONS CLOSELY ASSOCIATED WITH THEM

 

This notification sets out the details of awards over ordinary shares in Mediclinic ('Shares') granted to directors and other persons discharging managerial responsibilities ('PDMRs') on 5 August 2022 under the Company's short-term incentive scheme ('STI') and long-term incentive plan ('LTIP'), in accordance with the Remuneration Policy and share plan rules approved by shareholders at the annual general meeting of the Company held on 28 July 2022.

 

 

Name

 

Director/ PDMR

Number of Shares awarded under the STI

Number of Shares awarded under the LTIP

Dr Carel Aron van der Merwe

Director

74 718

237 716

Petrus Jurgens Myburgh

Director

47 488

148 319

David John Hadley

PDMR

n/a

58 369

Gert Cornelis Hattingh

PDMR

n/a

28 716

Dr Dirk Cornelius le Roux

PDMR

n/a

22 450

Dr Daniel Liedtke

PDMR

n/a

52 074

Magnus Oetiker

PDMR

n/a

51 945

Koert Hendrik Stefanus Pretorius

PDMR

n/a

30 055

Dr René Toua

PDMR

n/a

23 594

Dr Tyson Bruno Welzel

PDMR

n/a

40 608

Greg van Wyk

PDMR

n/a

27 270

 

 

The above awards were granted for nil consideration and are based on the closing price of a Share on 4 August 2022, which equates to £4.98 per Share.

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Dr Carel Aron van der Merwe

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Executive Officer - Mediclinic International plc 

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Short-Term Incentive scheme

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

74 718

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

74 718

 

£nil

 

e)

Date of the transaction

5 August 2022

 

f)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Long-Term Incentive Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

237 716

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

237 716

 

£nil

 

e)

Date of the transaction

5 August 2022

 

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Petrus Jurgens Myburgh

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Financial Officer - Mediclinic International plc  

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.1

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Short-Term Incentive scheme

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

47 488

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

47 488

 

£nil

 

e)

Date of the transaction

5 August 2022

 

f)

Place of the transaction

Outside a trading venue

4.2

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Long-Term Incentive Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

148 319

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

148 319

 

£nil

 

e)

Date of the transaction

5 August 2022

 

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

David John Hadley

 

2.

Reason for the notification

 

a)

Position / status

Chief Executive Officer - Mediclinic Middle East

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Long-Term Incentive Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

58 369

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

58 369

 

£nil

 

e)

Date of the transaction

5 August 2022

 

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Gert Cornelis Hattingh

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Governance Officer - Mediclinic International plc 

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Long-Term Incentive Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

28 716

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

28 716

 

£nil

 

e)

Date of the transaction

5 August 2022

 

 

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Dr Dirk Cornelius le Roux

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Information Officer - Mediclinic International plc 

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Long-Term Incentive Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

22 450

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

22 450

 

£nil

 

e)

Date of the transaction

5 August 2022

 

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Dr Daniel Liedtke

 

2.

Reason for the notification

 

a)

Position / status

Chief Executive Officer: Hirslanden

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Long-Term Incentive Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

52 074

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

52 074

 

£nil

 

e)

Date of the transaction

5 August 2022

 

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Magnus Oetiker

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Strategy Officer - Mediclinic International plc

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Long-Term Incentive Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

51 945

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

51 945

 

£nil

 

e)

Date of the transaction

5 August 2022

 

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Koert Hendrik Stefanus Pretorius

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Operating Officer - Mediclinic International plc

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Long-Term Incentive Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

30 055

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

30 055

 

£nil

 

e)

Date of the transaction

5 August 2022

 

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Dr René Toua

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Clinical Officer - Mediclinic International plc

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Long-Term Incentive Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

23 594

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

23 594

 

£nil

 

e)

Date of the transaction

5 August 2022

 

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Dr Tyson Bruno Welzel

 

2.

Reason for the notification

 

a)

Position / status

Group Chief Innovation Officer - Mediclinic International plc

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Long-Term Incentive Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

40 608

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

40 608

 

£nil

 

e)

Date of the transaction

5 August 2022

 

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them

 

a)

Name

Greg van Wyk

 

2.

Reason for the notification

 

a)

Position / status

Chief Executive Officer: Mediclinic Southern Africa

 

b)

Initial notification / amendment

Initial Notification

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

 

b)

LEI

2138002S5BSBIZTD5I60

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares

 

 

GB00B8HX8Z88

 

b)

Nature of the transaction

Award over ordinary shares in Mediclinic International plc granted at nil cost under the Company's Long-Term Incentive Plan

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

£nil

27 270

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

 

27 270

 

£nil

 

e)

Date of the transaction

5 August 2022

 

f)

Place of the transaction

Outside a trading venue

 

About Mediclinic International plc

 

Mediclinic is a diversified international private healthcare services group, established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia) and the Middle East.

 

The Group's core purpose is to enhance the quality of life.

 

Its vision is to be the partner of choice that people trust for all their healthcare needs.

 

Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders and regulators of healthcare in each of its markets.

 

At 30 June 2022, Mediclinic comprised 74 hospitals, five subacute hospitals, two mental health facilities, 20 day case clinics and 23 outpatient clinics. The Swiss operations included 17 hospitals and four day case clinics with around 1 900 inpatient beds; Southern Africa operations included 50 hospitals (three of which in Namibia), five subacute hospitals, two mental health facilities and 14 day case clinics (four of which operated by Intercare) across South Africa, and around 8 650 inpatient beds; and the Middle East operated seven hospitals, two day case clinics and 23 outpatient clinics with around 1 000 inpatient beds in the UAE. In addition, under management contract the Middle East will open a 200-bed hospital in the Kingdom of Saudi Arabia in 2023.

 

The Company's primary listing is on the London Stock Exchange ("LSE") in the United Kingdom, with secondary listings on the JSE in South Africa and the Namibian Stock Exchange in Namibia.

 

Mediclinic also holds a 29.7% interest in Spire Healthcare Group plc, a leading private healthcare group based in the United Kingdom and listed on the LSE.

 

 

For further information, please contact:

 

Company Secretary, Link Company Matters Limited

Caroline Emmet

+44 (0)333 300 1930

 

Investor Relations

James Arnold, Head of Investor Relations

ir@mediclinic.com

+44 (0)20 3786 8181

 

Media queries

FTI Consulting

Ben Atwell/Ciara Martin - United Kingdom

+44 (0)20 3727 1000

Sherryn Schooling - South Africa

+27 (0)21 487 9000

 

Registered address: 6th Floor, 65 Gresham Street, London, EC2V 7NQ, United Kingdom

Website: www.mediclinic.com

Corporate broker (United Kingdom): Morgan Stanley & Co International plc and UBS Investment Bank

JSE sponsor (South Africa): Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor (Namibia): Simonis Storm Securities (Pty) Ltd

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBDGDIXDGDGDU

Website Notice Block